JP2024519536A5 - - Google Patents

Info

Publication number
JP2024519536A5
JP2024519536A5 JP2023572137A JP2023572137A JP2024519536A5 JP 2024519536 A5 JP2024519536 A5 JP 2024519536A5 JP 2023572137 A JP2023572137 A JP 2023572137A JP 2023572137 A JP2023572137 A JP 2023572137A JP 2024519536 A5 JP2024519536 A5 JP 2024519536A5
Authority
JP
Japan
Prior art keywords
formula
group
ligase
pxr
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519536A (ja
Filing date
Publication date
Priority claimed from FR2105217A external-priority patent/FR3122989B1/fr
Application filed filed Critical
Publication of JP2024519536A publication Critical patent/JP2024519536A/ja
Publication of JP2024519536A5 publication Critical patent/JP2024519536A5/ja
Pending legal-status Critical Current

Links

JP2023572137A 2021-05-19 2022-05-18 Pxrを標的とする二官能性protac型化合物、同化合物を調製するための方法、及びその治療的使用 Pending JP2024519536A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR2105217 2021-05-19
FR2105217A FR3122989B1 (fr) 2021-05-19 2021-05-19 Nouveaux composes bifonctionnels de type protac ciblant pxr, leur procede de preparation et leur utilisation en therapeutique
PCT/EP2022/063422 WO2022243365A1 (fr) 2021-05-19 2022-05-18 Composés bifonctionnels de type protac ciblant pxr, leur procédé de préparation et leur utilisation en thérapeutique

Publications (2)

Publication Number Publication Date
JP2024519536A JP2024519536A (ja) 2024-05-15
JP2024519536A5 true JP2024519536A5 (https=) 2025-06-02

Family

ID=76284058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572137A Pending JP2024519536A (ja) 2021-05-19 2022-05-18 Pxrを標的とする二官能性protac型化合物、同化合物を調製するための方法、及びその治療的使用

Country Status (7)

Country Link
US (1) US20240252658A1 (https=)
EP (1) EP4340887A1 (https=)
JP (1) JP2024519536A (https=)
CN (1) CN117295523A (https=)
CA (1) CA3218875A1 (https=)
FR (1) FR3122989B1 (https=)
WO (1) WO2022243365A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118344284A (zh) * 2024-03-06 2024-07-16 杭州医学院 一种具有苯甲酰胺结构的化合物及其制备方法和应用
CN121735909A (zh) * 2024-09-27 2026-03-27 上海交通大学医学院附属瑞金医院 多价分子胶类化合物及其制备和应用
US20260092058A1 (en) 2024-09-30 2026-04-02 St. Jude Children's Research Hospital, Inc. Small Molecule Degraders and Fluorescent Probes of PXR

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017223415A1 (en) * 2016-06-23 2017-12-28 Dana-Farber Cancer Institute, Inc. Degradation of tripartite motif-containing protein 24 (trim24) by conjugation of trim24 inhibitors with e3 ligase ligand and methods of use

Similar Documents

Publication Publication Date Title
JP2024519536A5 (https=)
JP5503872B2 (ja) 核酸系代謝拮抗剤の高分子誘導体
ES2426599T3 (es) Formulación oral anticáncer
AU656689B2 (en) Multi-site metal chelating agents
JP5548365B2 (ja) 核酸系代謝拮抗剤の高分子誘導体
CA3035697A1 (en) Biaryl compounds useful as immunomodulators
US12606525B2 (en) Dimethyltryptamine analogues as nitric oxide delivery drugs
JP2010532380A5 (https=)
JP2007501862A5 (https=)
RU2007105350A (ru) 3-(гетероарилокси)-2-алкил-1-азабициклоалкильные производные, как лиганды альфа-7-nachr (никотиновых ацетилхолиновых рецепторов), предназначенные для лечения заболеваний центральной нервной системы
CA2653941A1 (en) Substituted amino purine derivatives and uses thereof
JP2020520926A5 (https=)
JP2020508985A5 (https=)
ES2785409T3 (es) Formas sólidas de un compuesto antiviral
US20230302144A1 (en) Porphyrin Compounds and Compositions Useful for Treating Cancer
JP2007505044A5 (https=)
JP2024501537A5 (https=)
TW200922623A (en) Polymeric drug delivery systems containing an aromatic allylic acid
JP2023505509A (ja) ポリエチレングリコール複合薬、ならびにその調製方法およびその使用
HU215129B (hu) Daganatellenes hatású, trinukleáris kationos platinakomplexek, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
JPH0725678B2 (ja) がん治療用白金挿入組成物
JP2005501121A5 (https=)
HUE029466T2 (en) Multifunctional nitroxide derivatives and their use
EP1140200B1 (en) Anthraquinone anticancer drugs
CN121620519A (zh) 新型GalNAc的靶向递送片段及其制备和应用